Submitted by Anonymous (not verified) on 25 October 2024 - 14:15
Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 19, Status: Authorised